Navigation Links
23 researchers join network of EMBO Young Investigators

HEIDELBERG, 6 NOVEMBER 2013 EMBO announced today the selection of 23 young researchers as EMBO Young Investigators. The scientists join a network of 315 current and past Young Investigators.

The Young Investigator Programme is for researchers under forty years of age who have established their first laboratories in the past four years. The successful candidates work in ten European countries, Israel and Singapore. The success rate for selection to this highly competitive programme was twelve per cent this year.

"The newly elected EMBO Young Investigators have the potential to be tomorrow's life science leaders," says Gerlind Wallon, EMBO Deputy Director and Manager of the Young Investigator Programme. "The status of Young Investigator offers a level of recognition that brings immediate benefits to scientists at an early stage of their careers."

Financial support includes 15,000 euros per year for three years directly from the member state where the laboratories of the scientists are located. The researchers receive a range of benefits to help start their first independent research laboratories. Laboratory management and non-scientific skills training as well as PhD courses offer the young group leaders and their students the chance to develop professional skills. The scientists also receive access to core facilities at EMBL and funding for themselves and their group members to attend conferences.


Contact: Barry Whyte
European Molecular Biology Organization

Page: 1

Related biology news :

1. Breakthrough by Temple researchers could lead to new treatment for heart attack
2. Temple researchers uncover clues to how existing heart drugs work
3. Researchers unmask centuries-old elephant imposter
4. Virginia Tech researchers explore natural way to displace harmful germs from household plumbing
5. Penn researchers identify molecular link between gut microbes and intestinal health
6. Researchers Able to Identify that Benign Tumors from Use of Oral Contraceptive Have a Greater Chance of Becoming Malignant
7. Children of lower socioeconomic status grow up more susceptible to catching colds, Carnegie Mellon researchers find
8. University of Louisville researchers sign global licensing agreement
9. BUSM researchers study epigenetic mechanisms of tumor metastasis for improved cancer therapy
10. Researchers quantify toxic ocean conditions during major extinction 93.9 million years ago
11. Researchers discover how cancer invisibility cloak works
Post Your Comments:
(Date:5/12/2016)... May 12, 2016 , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 /PRNewswire/ ... product subsidiary of Infosys (NYSE: INFY ), and ... global partnership that will provide end customers with ... banking and payment services.      (Logo: ... area for financial services, but it also plays a fundamental ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... Md. , June 23, 2016 A person ... from the crime scene to track the criminal down. ... the U.S. Food and Drug Administration (FDA) uses DNA evidence ... Sound far-fetched? It,s not. The FDA ... sequencing to support investigations of foodborne illnesses. Put as simply ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, doctors ... being treated for breast cancer benefitted from an injection of stem cells derived from ... frequent side effect of cancer treatment. , Lymphedema refers to the swelling ...
(Date:6/23/2016)... , June 23, 2016 On Wednesday, ... at 4,833.32, down 0.22%; the Dow Jones Industrial Average edged ... closed at 2,085.45, down 0.17%. has initiated coverage on ... ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals ... (NASDAQ: BIND ). Learn more about these stocks ...
Breaking Biology Technology: